Pharma Reaserch Prod Co Ltd Capital Reinvestment Ratio
Pharma Reaserch Prod Co Ltd capital reinvestment ratio. Pharma Reaserch Prod Co Ltd (214450) has a Capital Reinvestment Ratio of 0.13x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩61.53 Billion) in capital expenditures (₩7.79 Billion). Check 214450 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Pharma Reaserch Prod Co Ltd (2015–2025)
Capital reinvestment ratio of Pharma Reaserch Prod Co Ltd from 2015 to 2025. This chart tracks Pharma Reaserch Prod Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Also explore net asset growth rate of Pharma Reaserch Prod Co Ltd to track the company's year-over-year net asset growth rate.
Pharma Reaserch Prod Co Ltd Capital Reinvestment Ratio by Year (2015–2025)
Pharma Reaserch Prod Co Ltd capital reinvestment ratio by year from 2015 to 2025. For the full cash flow conversion analysis, see 214450 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | ₩183.16 Billion | ₩35.78 Billion | ▼ -29.4% |
| 2024 | 0.28x | ₩139.88 Billion | ₩38.73 Billion | ▲ +36.2% |
| 2023 | 0.20x | ₩64.95 Billion | ₩13.20 Billion | ▼ -32.0% |
| 2022 | 0.30x | ₩59.40 Billion | ₩17.76 Billion | ▼ -5.5% |
| 2021 | 0.32x | ₩65.30 Billion | ₩20.64 Billion | ▼ -70.6% |
| 2020 | 1.07x | ₩32.39 Billion | ₩34.78 Billion | ▲ +115.9% |
| 2019 | 0.50x | ₩19.27 Billion | ₩9.59 Billion | ▼ -91.0% |
| 2018 | 5.50x | ₩5.20 Billion | ₩28.60 Billion | ▲ +516.2% |
| 2017 | 0.89x | ₩8.56 Billion | ₩7.63 Billion | ▲ +271.8% |
| 2016 | 0.24x | ₩8.16 Billion | ₩1.96 Billion | ▲ +730.2% |
| 2015 | 0.03x | ₩16.02 Billion | ₩462.99 Million | — |